{"hands_on_practices": [{"introduction": "In flow cytometry, accurate diagnosis hinges on the quality of the data. This first practice explores a critical aspect of data integrity: distinguishing live cells from dead cells. This exercise presents a common diagnostic pitfall where nonspecific antibody binding to dead cells can create false-positive signals, potentially leading to a misdiagnosis. By analyzing the provided data [@problem_id:5226103], you will learn to recognize this artifact and understand why viability gating is an indispensable first step in any immunophenotyping analysis.", "problem": "A laboratory is immunophenotyping a suspected B-cell Acute Lymphoblastic Leukemia (B-ALL) using Flow Cytometry (FC). The panel includes CD19, CD10, CD34, CD45, and CD7, with isotype controls measured in parallel. The technologist acquires $n = 10^5$ events from a bone marrow aspirate. Blasts are gated by low CD45 and intermediate side scatter (SSC), then analyzed for CD7 expression. Dead cell exclusion is not initially applied. A second acquisition is then performed with a fixable amine-reactive viability dye and dead cells excluded.\n\nFoundational base to use:\n- Antigen–antibody binding occurs via specific complementarity of paratopes to epitopes; nonspecific binding increases when membrane integrity is lost due to enhanced permeability and exposure of intracellular binding sites and charged macromolecules.\n- In FC, fluorescence intensity reflects the number of fluorochrome molecules associated with a cell; Median Fluorescence Intensity (MFI) across a population summarizes signal distribution.\n- Viability dyes (for example, 7-Aminoactinomycin D (7-AAD) or fixable amine-reactive dyes) preferentially label cells with compromised membranes because intracellular amines become accessible, allowing separation of live from dead events.\n- Laboratory positivity is defined by an MFI ratio to the isotype control threshold of $> 2.0$ for a marker in the blast gate, and separately by percent-positive cells of >20% above a fixed fluorescence threshold.\n\nObserved data for CD7 in the blast gate:\n- Without viability gating: CD7 MFI $= 287.5$, isotype MFI $= 125$, percent-positive $= 28\\%$.\n- With viability gating (dead excluded): CD7 MFI $= 150$, isotype MFI $= 100$, percent-positive $= 8\\%$.\n\nAdditional single-cell measurements show that the subset identified as dead (strong viability dye signal) has CD7 fluorescence much higher than live blasts, and the dead subset comprises approximately $p_d = 0.25$ of blast-gated events in the ungated acquisition.\n\nA junior analyst suggests that the apparent CD7 positivity without viability gating indicates true aberrant T-lineage marker expression and potential mixed phenotype acute leukemia, while the senior scientist insists that the CD7 signal is an artifact of nonspecific antibody binding to dead cells and must be excluded before interpretation.\n\nWhich option best justifies, from first principles and the provided observations, why dead cell exclusion is critical to avoid nonspecific antibody binding that can mimic aberrant antigen expression in leukemias?\n\nA. Compromised membrane integrity in dead cells increases permeability and exposes intracellular amines and charged macromolecules, promoting nonspecific uptake and retention of fluorochrome-conjugated antibodies and isotype controls. Because FC reports population MFIs and percent-positive based on thresholds, inclusion of a high-fluorescence dead subset (here $p_d = 0.25$) shifts the weighted signals above positivity criteria (MFI ratio $= 287.5/125 = 2.30$ and $28\\%$ positive), although live blasts remain below thresholds (MFI ratio $= 150/100 = 1.50$ and $8\\%$ positive). Viability gating removes this nonspecific contribution, restoring biologically valid assessment of antigen expression.\n\nB. FC compensation algorithms assume all cells are alive and therefore miscompute spectral spillover when dead cells are present; excluding dead cells is necessary to prevent mathematical divergence of spillover coefficients, which otherwise causes instrument saturation independent of antigen binding.\n\nC. Dead cells rapidly upregulate lineage-inappropriate antigens post-mortem due to stress-induced transcription, revealing true aberrant expression; excluding them prevents misclassification but is not essential for interpreting antibody specificity.\n\nD. Dead cells lower forward scatter ($FSC$), biasing size estimates; excluding them primarily corrects size gating and thus indirectly fixes antigen quantification, since fluorescence intensity is determined by cell size rather than antibody binding specificity.", "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Context:** Immunophenotyping of suspected B-cell Acute Lymphoblastic Leukemia (B-ALL) via Flow Cytometry (FC).\n- **Sample:** Bone marrow aspirate with $n = 10^5$ events acquired.\n- **Antibody Panel:** CD19, CD10, CD34, CD45, CD7, and isotype controls.\n- **Gating:** Blasts are defined by low CD45 expression and intermediate side scatter (SSC).\n- **Foundational Principles:**\n    1.  Nonspecific antibody binding increases when cell membrane integrity is lost.\n    2.  Median Fluorescence Intensity (MFI) is a measure of signal distribution in a population.\n    3.  Viability dyes separate live from dead cells based on membrane integrity.\n    4.  Positivity Criteria: MFI ratio to isotype $> 2.0$, or percent-positive cells $> 20\\%$.\n- **Data for CD7 in the blast gate (Without Viability Gating):**\n    - CD7 MFI $= 287.5$\n    - Isotype MFI $= 125$\n    - Percent-positive CD7 $= 28\\%$\n- **Data for CD7 in the blast gate (With Viability Gating, dead cells excluded):**\n    - CD7 MFI $= 150$\n    - Isotype MFI $= 100$\n    - Percent-positive CD7 $= 8\\%$\n- **Additional Information:**\n    - The subset of dead cells has much higher CD7 fluorescence than live blasts.\n    - The proportion of dead cells within the blast gate is $p_d = 0.25$.\n- **Question:** Justify, from first principles and the data, why dead cell exclusion is critical to avoid artifacts from nonspecific antibody binding.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem is firmly rooted in the established principles of flow cytometry and clinical immunology. The phenomenon of increased nonspecific antibody binding to dead cells is a well-known artifact that necessitates the use of viability dyes. The markers, cell types, and data values presented are realistic for a diagnostic hematopathology scenario. The principles provided are correct.\n- **Well-Posed:** The problem provides a clear scenario, quantitative data, and a set of explicit principles. The question asks for a specific justification based on this information, which allows for a single, logical, and derivable conclusion. The problem is self-contained.\n- **Objective:** The problem statement is presented using precise, technical language. It describes a common laboratory discrepancy and asks for the scientific explanation, free of subjective or opinion-based content.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is scientifically sound, well-posed, objective, and contains sufficient information to derive a unique solution and evaluate the provided options. The solution process will now proceed.\n\n### Principle-Based Derivation\nThe core task is to determine why the initial observation of CD7 positivity on the blast population is reversed after excluding dead cells. We will use the provided data and principles to evaluate the two conditions.\n\n**Condition 1: Without Viability Gating**\nThe total population within the blast gate consists of both live and dead cells.\n- The MFI ratio for CD7 relative to its isotype control is calculated as:\n$$ \\text{MFI Ratio} = \\frac{\\text{CD7 MFI}}{\\text{Isotype MFI}} = \\frac{287.5}{125} = 2.30 $$\n- The percentage of cells positive for CD7 is given as $28\\%$.\n- According to the positivity criteria (MFI ratio $> 2.0$ or percent-positive $> 20\\%$), the blast population appears to be positive for CD7, as both criteria are met ($2.30 > 2.0$ and $28\\% > 20\\%$). This would suggest aberrant T-lineage marker expression, potentially indicating a mixed phenotype acute leukemia.\n\n**Condition 2: With Viability Gating (Live Cells Only)**\nAfter excluding dead cells, the analysis is restricted to the live blast population.\n- The MFI ratio for CD7 relative to its isotype control is now:\n$$ \\text{MFI Ratio} = \\frac{\\text{CD7 MFI}}{\\text{Isotype MFI}} = \\frac{150}{100} = 1.50 $$\n- The percentage of cells positive for CD7 is given as $8\\%$.\n- According to the positivity criteria, the live blast population is negative for CD7, as neither criterion is met ($1.50 \\ngtr 2.0$ and $8\\% \\ngtr 20\\%$).\n\n**Reconciling the Discrepancy**\nThe foundational principles state that loss of membrane integrity in dead cells leads to increased nonspecific binding. The data fully support this principle. The total MFI of a mixed population is a weighted average of the MFIs of its subpopulations. Let the subscripts 'total', 'live', and 'dead' denote the entire population, the live subset, and the dead subset, respectively. The proportion of dead cells is $p_d = 0.25$, so the proportion of live cells is $p_{live} = 1 - p_d = 0.75$.\n\nThe total MFI can be approximated as:\n$$ MFI_{total} \\approx (p_{live} \\cdot MFI_{live}) + (p_d \\cdot MFI_{dead}) $$\nFor the CD7 antibody:\n$$ 287.5 \\approx (0.75 \\cdot 150) + (0.25 \\cdot MFI_{dead, CD7}) $$\n$$ 287.5 \\approx 112.5 + (0.25 \\cdot MFI_{dead, CD7}) $$\n$$ 175 \\approx 0.25 \\cdot MFI_{dead, CD7} \\implies MFI_{dead, CD7} \\approx 700 $$\nFor the isotype control:\n$$ 125 \\approx (0.75 \\cdot 100) + (0.25 \\cdot MFI_{dead, Isotype}) $$\n$$ 125 \\approx 75 + (0.25 \\cdot MFI_{dead, Isotype}) $$\n$$ 50 \\approx 0.25 \\cdot MFI_{dead, Isotype} \\implies MFI_{dead, Isotype} \\approx 200 $$\n\nThese calculations confirm that the dead cell subset must have significantly higher fluorescence for both the specific antibody ($MFI \\approx 700$) and the isotype control ($MFI \\approx 200$) compared to the live cells (CD7 MFI $= 150$, Isotype MFI $= 100$). The high signal from the isotype control on dead cells is the definitive hallmark of nonspecific binding. This nonspecific binding is due to the compromised membranes of dead cells, which allows antibodies to enter and bind to intracellular structures and charged macromolecules, as stated in the principles.\n\nThe inclusion of this highly fluorescent, but nonspecifically stained, dead cell population ($25\\%$ of events) artificially inflates the overall MFI and percent-positive values for the entire gate, leading to a false-positive interpretation. By using a viability dye to exclude these dead cells, the analysis is confined to the live cells, revealing their true, biologically relevant immunophenotype, which in this case is negative for CD7. This invalidates the junior analyst's hypothesis and supports the senior scientist's insistence on excluding the artifact.\n\n### Option-by-Option Analysis\n**A. Compromised membrane integrity in dead cells increases permeability and exposes intracellular amines and charged macromolecules, promoting nonspecific uptake and retention of fluorochrome-conjugated antibodies and isotype controls. Because FC reports population MFIs and percent-positive based on thresholds, inclusion of a high-fluorescence dead subset (here $p_d = 0.25$) shifts the weighted signals above positivity criteria (MFI ratio $= 287.5/125 = 2.30$ and $28\\%$ positive), although live blasts remain below thresholds (MFI ratio $= 150/100 = 1.50$ and $8\\%$ positive). Viability gating removes this nonspecific contribution, restoring biologically valid assessment of antigen expression.**\nThis option perfectly aligns with the provided principles and the quantitative analysis derived from the data. It correctly identifies nonspecific binding due to membrane permeability as the cause, accurately uses the data to show how the dead cell subset skews the results to create a false positive, and correctly concludes that viability gating is essential to remove this artifact.\n**Verdict: Correct**\n\n**B. FC compensation algorithms assume all cells are alive and therefore miscompute spectral spillover when dead cells are present; excluding dead cells is necessary to prevent mathematical divergence of spillover coefficients, which otherwise causes instrument saturation independent of antigen binding.**\nThis option is incorrect. The primary artifact described is nonspecific binding, not an error in fluorescence compensation. Compensation corrects for spectral overlap between different fluorochromes, which is not the central issue here. While dead cells can have different autofluorescence spectra, this does not cause compensation coefficients to \"diverge,\" nor is it the direct cause of the false positivity observed for a single marker. The problem is the amount of antibody bound, not its spectral properties.\n**Verdict: Incorrect**\n\n**C. Dead cells rapidly upregulate lineage-inappropriate antigens post-mortem due to stress-induced transcription, revealing true aberrant expression; excluding them prevents misclassification but is not essential for interpreting antibody specificity.**\nThis option is biologically false. Cell death involves the cessation of active cellular processes like transcription and translation. Dead cells cannot \"upregulate\" antigens. The increased fluorescence is due to passive, nonspecific uptake of antibodies through a leaky membrane. Therefore, the observed signal is not \"true aberrant expression,\" and excluding these cells is absolutely essential for correct interpretation.\n**Verdict: Incorrect**\n\n**D. Dead cells lower forward scatter ($FSC$), biasing size estimates; excluding them primarily corrects size gating and thus indirectly fixes antigen quantification, since fluorescence intensity is determined by cell size rather than antibody binding specificity.**\nThis option misidentifies the root cause and contains a fundamentally incorrect premise. While dead cells often have altered light scatter properties (FSC and SSC), the primary reason for excluding them is their compromised membrane integrity leading to nonspecific binding, not their size. The statement that \"fluorescence intensity is determined by cell size rather than antibody binding specificity\" is false. In immunophenotyping, fluorescence intensity is primarily a function of the number of specifically bound antibodies, which reflects the antigen expression level.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "5226103"}, {"introduction": "A fundamental hallmark of a B-cell cancer is clonality, meaning the malignancy arises from a single ancestral cell. We can detect this by examining the expression of immunoglobulin light chains, which are normally a balanced mix of kappa ($\\kappa$) and lambda ($\\lambda$) types in a healthy population. This practice challenges you to apply statistical principles to flow cytometry counts to assess clonality [@problem_id:5226106]. You will move beyond a simple ratio calculation to construct a confidence interval, learning how to quantify the uncertainty in your measurement and make a statistically sound judgment about whether a B-cell population is neoplastic.", "problem": "A flow cytometry immunophenotyping study of B-lymphocytes gated on cluster of differentiation 19 positive (CD19+) events is performed to assess light chain restriction as part of laboratory diagnostics for suspected clonal lymphoproliferative disease. Among the CD19+ gate, there are $800$ events positive for kappa light chain and $100$ events positive for lambda light chain. Assume that within this gate every event expresses exactly one light chain (no double-positives or double-negatives) and that each event can be modeled as an independent Bernoulli trial for “kappa” versus “lambda” assignment.\n\nStarting from the binomial model and the Central Limit Theorem, define the observed kappa proportion $\\hat{p}$ and its sampling variability, derive an approximate two-sided $95\\%$ Confidence Interval (CI) for the true kappa proportion $p$, and then use the monotonic transformation $R = \\frac{p}{1-p}$ to obtain an approximate $95\\%$ CI for the true kappa-to-lambda ratio $R$. Interpret whether the B-cell population is likely clonal, using as a well-tested reference that polyclonal surface immunoglobulin light chain ratios in reactive samples typically fall within $0.5$ to $3.0$.\n\nReport the kappa-to-lambda ratio computed from the observed counts as your final numeric answer. Round this ratio to three significant figures. Express the final ratio as a pure number with no units.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of laboratory diagnostics (immunophenotyping) and biostatistics (binomial model, Central Limit Theorem, confidence intervals). The problem is well-posed, providing all necessary data and a clear, objective question. The given values and reference ranges are realistic within the clinical context.\n\nLet $n_k$ be the number of observed events positive for the kappa light chain and $n_l$ be the number of observed events positive for the lambda light chain.\nFrom the problem statement, we are given:\n$n_k = 800$\n$n_l = 100$\n\nThe total number of B-lymphocyte events, $N$, within the CD19+ gate is the sum of kappa and lambda positive events, as it is stated that every event expresses exactly one light chain.\n$$N = n_k + n_l = 800 + 100 = 900$$\n\nLet $p$ be the true proportion of kappa-positive cells in the underlying B-cell population. Each cell is considered an independent Bernoulli trial with a probability $p$ of being kappa-positive and a probability $1-p$ of being lambda-positive. The number of kappa-positive cells, $X_k$, in a sample of size $N$ follows a binomial distribution, $X_k \\sim \\text{Binomial}(N, p)$.\n\nThe observed proportion of kappa-positive cells, $\\hat{p}$, is the point estimate for $p$:\n$$\\hat{p} = \\frac{n_k}{N} = \\frac{800}{900} = \\frac{8}{9}$$\n\nAccording to the Central Limit Theorem, for a large sample size $N$ (here $N=900$, which is sufficiently large), the sampling distribution of the sample proportion $\\hat{p}$ can be approximated by a normal distribution:\n$$\\hat{p} \\approx \\mathcal{N}\\left(p, \\frac{p(1-p)}{N}\\right)$$\nThe standard error of the proportion, $SE(\\hat{p})$, is given by $\\sqrt{\\frac{p(1-p)}{N}}$. For the purpose of constructing a confidence interval, we approximate the standard error by substituting the sample proportion $\\hat{p}$ for the true proportion $p$:\n$$SE(\\hat{p}) \\approx \\sqrt{\\frac{\\hat{p}(1-\\hat{p})}{N}} = \\sqrt{\\frac{(\\frac{8}{9})(1 - \\frac{8}{9})}{900}} = \\sqrt{\\frac{(\\frac{8}{9})(\\frac{1}{9})}{900}} = \\sqrt{\\frac{8}{81 \\times 900}} = \\frac{\\sqrt{8}}{9 \\times 30} = \\frac{2\\sqrt{2}}{270} = \\frac{\\sqrt{2}}{135}$$\n\nAn approximate two-sided $95\\%$ confidence interval (CI) for the true proportion $p$ is given by the formula:\n$$\\text{CI}_p = \\hat{p} \\pm z_{\\alpha/2} \\cdot SE(\\hat{p})$$\nFor a $95\\%$ CI, the significance level is $\\alpha = 0.05$, so $\\alpha/2 = 0.025$. The corresponding critical value from the standard normal distribution is $z_{0.025} \\approx 1.96$.\nThe $95\\%$ CI for $p$ is:\n$$\\text{CI}_p = \\left[ \\frac{8}{9} - 1.96 \\frac{\\sqrt{2}}{135}, \\frac{8}{9} + 1.96 \\frac{\\sqrt{2}}{135} \\right]$$\nNumerically, the interval is approximately:\n$$p_{lower} \\approx 0.8889 - 1.96 \\left(\\frac{1.4142}{135}\\right) \\approx 0.8889 - 0.0205 = 0.8684$$\n$$p_{upper} \\approx 0.8889 + 1.96 \\left(\\frac{1.4142}{135}\\right) \\approx 0.8889 + 0.0205 = 0.9094$$\nSo, $\\text{CI}_p \\approx [0.8684, 0.9094]$.\n\nThe problem requires a $95\\%$ CI for the true kappa-to-lambda ratio, $R = \\frac{p}{1-p}$. The function $f(p) = \\frac{p}{1-p}$ is monotonically increasing for $p \\in (0,1)$. Therefore, we can obtain the CI for $R$ by applying this transformation to the endpoints of the CI for $p$.\nThe lower bound for $R$ is:\n$$R_{lower} = \\frac{p_{lower}}{1-p_{lower}} \\approx \\frac{0.8684}{1-0.8684} = \\frac{0.8684}{0.1316} \\approx 6.5988$$\nThe upper bound for $R$ is:\n$$R_{upper} = \\frac{p_{upper}}{1-p_{upper}} \\approx \\frac{0.9094}{1-0.9094} = \\frac{0.9094}{0.0906} \\approx 10.0375$$\nThus, the approximate $95\\%$ CI for the true kappa-to-lambda ratio $R$ is $[6.60, 10.04]$.\n\nTo interpret this result, we compare the CI to the reference range for polyclonal B-cell populations, which is given as $0.5$ to $3.0$. The calculated $95\\%$ confidence interval for the true ratio, $[6.60, 10.04]$, lies entirely outside and above this reference range. This indicates with high confidence that the true ratio is abnormal. Such a marked elevation and restriction to one light chain type (kappa) is a hallmark of a clonal process, strongly suggesting a B-cell lymphoproliferative disorder.\n\nThe final task is to report the kappa-to-lambda ratio computed from the observed counts, rounded to three significant figures. This is the sample ratio, $\\hat{R}$.\n$$\\hat{R} = \\frac{n_k}{n_l} = \\frac{800}{100} = 8$$\nTo express this value with three significant figures, we write it as $8.00$.", "answer": "$$\\boxed{8.00}$$", "id": "5226106"}, {"introduction": "Arriving at a specific diagnosis, such as Mantle Cell Lymphoma, is rarely based on a single marker but rather on synthesizing a pattern of evidence from a full antibody panel. This final exercise introduces a powerful quantitative framework for this diagnostic reasoning process using Bayes' theorem [@problem_id:5226054]. You will learn how to combine the diagnostic power of multiple independent markers to calculate the updated probability of a disease, transforming a complex immunophenotype into a clear, data-driven conclusion that can guide crucial clinical decisions.", "problem": "A clinical flow cytometry case presents a clonal B-cell population with the following immunophenotype: Cluster of Differentiation 19 positive (CD19+), Cluster of Differentiation 5 positive (CD5+), Cluster of Differentiation 23 negative (CD23-), Cluster of Differentiation 200 negative (CD200-), FMC7 positive (FMC7+), and surface Immunoglobulin (sIg) bright. You are asked to quantify how strongly this phenotype supports Mantle Cell Lymphoma (MCL) over other small mature B-cell neoplasms in the subclass of CD19+CD5+ clonal lymphocytoses.\n\nUse the following foundational facts and assumptions:\n- Prior probability: Among CD19+CD5+ clonal B-cell proliferations, the prior probability of Mantle Cell Lymphoma (MCL) is $0.15$.\n- For each observed feature $X$ in the set $\\{ \\text{CD23}^-, \\text{CD200}^-, \\text{FMC7}^+, \\text{sIg bright} \\}$, the laboratory has validated the following conditional probabilities:\n  - $P(\\text{CD}23^{-} \\mid \\text{MCL}) = 0.88$, $P(\\text{CD}23^{-} \\mid \\neg\\text{MCL}) = 0.10$.\n  - $P(\\text{CD}200^{-} \\mid \\text{MCL}) = 0.92$, $P(\\text{CD}200^{-} \\mid \\neg\\text{MCL}) = 0.08$.\n  - $P(\\text{FMC}7^{+} \\mid \\text{MCL}) = 0.85$, $P(\\text{FMC}7^{+} \\mid \\neg\\text{MCL}) = 0.20$.\n  - $P(\\text{sIg bright} \\mid \\text{MCL}) = 0.80$, $P(\\text{sIg bright} \\mid \\neg\\text{MCL}) = 0.15$.\n- Conditional independence: Given the disease state (MCL vs. not MCL), the listed features are conditionally independent.\n- CD19+ and CD5+ are the pre-selection criteria defining the reference population and should not be used again as evidence in the likelihood.\n\nTasks:\n1. Using Bayes’ theorem in odds form and the conditional independence assumption, compute the posterior probability $P(\\text{MCL} \\mid \\text{data})$ for the observed data $\\{\\text{CD23}^{-}, \\text{CD200}^{-}, \\text{FMC7}^{+}, \\text{sIg bright}\\}$.\n2. Institutional reflex policy: Order Fluorescence In Situ Hybridization (FISH) for the translocation $t(11;14)(q13;q32)$ if $P(\\text{MCL} \\mid \\text{data}) \\geq 0.70$. Identify the appropriate FISH probe strategy (for example, Immunoglobulin Heavy Chain (IGH)-Cyclin D$1$ (CCND$1$) dual-fusion probes) based on this rule. Do not include this selection in your final numeric answer.\n\nExpress the final posterior probability as a decimal without a percentage sign, and round your answer to $4$ significant figures.", "solution": "The problem requires the calculation of the posterior probability of a diagnosis of Mantle Cell Lymphoma (MCL) given a specific immunophenotypic data set, within a pre-selected population of CD19+CD5+ clonal B-cell proliferations. The problem is a direct application of Bayes' theorem. We are given the prior probability of MCL and the conditional probabilities of several markers, and we are instructed to assume conditional independence of these markers.\n\nLet $H$ be the hypothesis that the patient has Mantle Cell Lymphoma, so $H = \\text{MCL}$. Let $\\neg H$ be the alternative hypothesis, $\\neg H = \\neg\\text{MCL}$. The provided immunophenotypic evidence, which we will denote as $E$, is the set of observations $E = \\{ \\text{CD23}^-, \\text{CD200}^-, \\text{FMC7}^+, \\text{sIg bright} \\}$. We are tasked with computing $P(H \\mid E)$.\n\nThe problem suggests using Bayes' theorem in odds form. The prior odds in favor of MCL are defined as:\n$$ O(H) = \\frac{P(H)}{P(\\neg H)} = \\frac{P(\\text{MCL})}{1 - P(\\text{MCL})} $$\nGiven the prior probability $P(\\text{MCL}) = 0.15$, the prior odds are:\n$$ O(H) = \\frac{0.15}{1 - 0.15} = \\frac{0.15}{0.85} = \\frac{15}{85} = \\frac{3}{17} $$\n\nThe posterior odds, $O(H \\mid E)$, are related to the prior odds by the Bayes Factor, $BF$, which is the overall likelihood ratio $\\frac{P(E \\mid H)}{P(E \\mid \\neg H)}$:\n$$ O(H \\mid E) = O(H) \\times \\frac{P(E \\mid H)}{P(E \\mid \\neg H)} $$\n\nThe crucial assumption of conditional independence for the features in $E$ given the disease state allows us to calculate the Bayes Factor as the product of the individual likelihood ratios (LR) for each feature. Let $E_1 = \\text{CD}23^{-}$, $E_2 = \\text{CD}200^{-}$, $E_3 = \\text{FMC}7^{+}$, and $E_4 = \\text{sIg bright}$. Then:\n$$ BF = \\frac{P(E \\mid H)}{P(E \\mid \\neg H)} = \\prod_{i=1}^{4} \\frac{P(E_i \\mid H)}{P(E_i \\mid \\neg H)} = LR_1 \\times LR_2 \\times LR_3 \\times LR_4 $$\n\nWe calculate each likelihood ratio using the provided conditional probabilities:\n1.  For $E_1 = \\text{CD}23^{-}$:\n    $LR_1 = \\frac{P(\\text{CD}23^{-} \\mid \\text{MCL})}{P(\\text{CD}23^{-} \\mid \\neg\\text{MCL})} = \\frac{0.88}{0.10} = 8.8$\n\n2.  For $E_2 = \\text{CD}200^{-}$:\n    $LR_2 = \\frac{P(\\text{CD}200^{-} \\mid \\text{MCL})}{P(\\text{CD}200^{-} \\mid \\neg\\text{MCL})} = \\frac{0.92}{0.08} = 11.5$\n\n3.  For $E_3 = \\text{FMC}7^{+}$:\n    $LR_3 = \\frac{P(\\text{FMC}7^{+} \\mid \\text{MCL})}{P(\\text{FMC}7^{+} \\mid \\neg\\text{MCL})} = \\frac{0.85}{0.20} = 4.25$\n\n4.  For $E_4 = \\text{sIg bright}$:\n    $LR_4 = \\frac{P(\\text{sIg bright} \\mid \\text{MCL})}{P(\\text{sIg bright} \\mid \\neg\\text{MCL})} = \\frac{0.80}{0.15} = \\frac{80}{15} = \\frac{16}{3}$\n\nThe composite Bayes Factor is the product of these individual likelihood ratios:\n$$ BF = 8.8 \\times 11.5 \\times 4.25 \\times \\frac{16}{3} $$\n$$ BF = (101.2) \\times 4.25 \\times \\frac{16}{3} $$\n$$ BF = 430.1 \\times \\frac{16}{3} = \\frac{6881.6}{3} $$\n\nNow, we can compute the posterior odds:\n$$ O(H \\mid E) = O(H) \\times BF = \\frac{3}{17} \\times \\frac{6881.6}{3} = \\frac{6881.6}{17} = 404.8 $$\n\nFinally, we convert the posterior odds back to the posterior probability, $P(H \\mid E)$:\n$$ P(H \\mid E) = \\frac{O(H \\mid E)}{1 + O(H \\mid E)} $$\n$$ P(\\text{MCL} \\mid E) = \\frac{404.8}{1 + 404.8} = \\frac{404.8}{405.8} \\approx 0.997535707... $$\n\nRounding the result to $4$ significant figures as requested gives $0.9975$.\n\nFor the second task, the institutional reflex policy requires ordering Fluorescence In Situ Hybridization (FISH) for the translocation $t(11;14)(q13;q32)$ if $P(\\text{MCL} \\mid \\text{data}) \\geq 0.70$. Our calculated probability is approximately $0.9975$, which is well above the threshold of $0.70$. Therefore, according to the policy, a confirmatory FISH test should be ordered. The appropriate probe strategy targets the specific genes involved in this pathognomonic translocation: an Immunoglobulin Heavy Chain (IGH)-Cyclin D$1$ (CCND$1$) dual-color fusion probe set is the correct choice to detect the $t(11;14)$ rearrangement.", "answer": "$$\n\\boxed{0.9975}\n$$", "id": "5226054"}]}